Donate
WHAT WE FUND

Idiopathic pulmonary fibrosis

Respiratory diseases

At a glance

Elk1 as a master regulator of fibrogenesis: An investigation of the molecular mechanisms through which Elk1 may regulate lung fibrosis

Lead researcher

Dr Amanda Tatler

Institution

University of Nottingham

Status

Completed

Amount awarded

£245,732.00

Last updated

08/01/24

Share

A fellowship to look at how low levels of a protein called Elk1 leads to the development of significantly worse scarring of the lung in patients with idiopathic pulmonary fibrosis (IPF).

Dr Tatler’s study will use state-of-art molecular techniques to identify different biological pathways that may be important in IPF.

We awarded Dr Amanda Tatler from the University of Nottingham a fellowship to look at how low levels of a protein called Elk1 leads to the development of significantly worse scarring of the lung in patients with idiopathic pulmonary fibrosis (IPF). Elk1 is expressed by all cells in the body and is responsible for switching certain genes on or off when required by a cell.

Elk1 might act as a “brake” on the scarring process that characterises IPF and block the progression and development of IPF. It is known that patients with IPF have lower levels of the “brake” Elk1 than patients not suffering from IPF. Dr Tatler’s study will use state-of-art molecular techniques to identify different biological pathways that may be important in IPF and are affected by the loss of Elk1 observed in IPF patients.

The study aims to analyse the role that Elk1 may play as a master regulator of scarring in human IPF patients and shed important light on how IPF is initiated and progresses.

Get in touch

To find out more about the research we fund and the difference it makes.

Contact us

Respiratory Diseases – Idiopathic pulmonary fibrosis

  • Why there is a need to fund new research

    Idiopathic pulmonary fibrosis (IPF) is an incurable rare lung disease. 15,000 people in the UK are living with IPF. The key feature of IPF is the irreversible build-up of dense scar tissue within the air spaces of the lungs, which leads to breathlessness and ultimately respiratory failure. The causes are unknown, and current treatments do not stop the progression of disease, only slow it down.

Support us

Help change lives

We fund and support the most promising health research wherever we discover great opportunities that are not being pursued. We use our donations responsibly and ensure we make the greatest impact where it is most needed.

DONATE
Couple Laughing Outdoors